Abstract

A newly developed surface analysis technique, which combines secondary ion mass spectrometry with angle-resolved X-ray photoelectron spectroscopy, was used to achieve more accurate results of the retained impurity doses and profiles for ultralow-energy implants, including conventional beamline implant and plasma immersion ion implantation (PIII). Using this method, it has been found that the B <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub> H <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">6</sub> (diborane) PIII demonstrates thicker native oxide and much more B dose loss during rapid thermal processing and surface-cleaning treatments than conventional beamline ion implantation, due to the higher surface B concentration. In order to match the electrical parameters of the device, PIII must consider higher nominal dose to compensate the B loss.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call